ClinicalTrials.Veeva

Menu

Hair Transplantation in Cicatricial Alopecia

A

Alexandria University

Status

Completed

Conditions

Cicatricial Alopecia
Hair Transplantation

Treatments

Procedure: follicular unit extarcation and platelet rich plasma

Study type

Interventional

Funder types

Other

Identifiers

NCT04472715
00007555

Details and patient eligibility

About

follicular unit extraction as a method of hair transplantation in cicatricial alopecia

Full description

The study will include 20 patients with cicatrical alopecia.Patients will be randomly assigned into two groups:Group (A):include ten patients will undergo (FUE) alone.

Group (B): include ten patients will undergo(FUE) and (PRP).3-Surgical technique:

Preoperative Investigations including complete blood count, coagulation profile and hepatitis viral markers.

1-Group(A): will undergo (FUE)

Washing the scalp with antiseptic shampoo before the procedure. Tumuscentanaesthesia:The donor area is anesthetized with a lidocaine 1% solution diluted with 20 cc saline in addition to adrenaline. Creation of micropunches(0.7-1 mm) using micromotor. After removal of the punch,the follicular unit is extracted with Jweler's forceps. Extracted grafts are then placed on chilled saline gauze for maximum four hours until ready for transplantation. The recipient area is prepared with rectangular scalpel blades 1mm or hypodermic blades 0.9 mm. Implantation using fine tipped jweler's forceps.

Finally, receptor and donor areas will be softly cleansed with saline and crepe bandage is applied.

2-Group (B): FUE+PRP

The same procedure will be done but grafts will be placed in Prp solution. Prp session one week before transplantation then monthly for 3 monthes after (FUE). Preparation of PRP 10 cc blood will be aspirated in test tube contained a modified solution of anticoagulant,called acid-citrate-dextrose type (ACDA), in which the physiological pH will reached to preserve the platelet integrity. The first spin of whole blood sample will be at 2500 rpm for 4 minutes The second spin at 4000 for 20 minutes for obtained plasma. Platelets are separated as a pellet at the bottom of the tube from platelet-poor plasma (PPP) above. The platelet-rich pellet is resuspended in remaining amount of plasma. The resulting suspension is used as PRP. Prp is injected in the recipient area. 4-Follow up: Follow up clinically by digital photographs and trichoscopy 1 week after operation, after 3 months and after 6 months.

Enrollment

20 patients

Sex

All

Ages

18 to 50 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • • Patients with unacceptable visible scarring alopecia.

    • Adequate donor area.
    • patient free of signs of disease activity evidenced by trichoscopy.
    • Patients having inadequate laxity for a strip excision (too tight skin).
    • When previous scars of strip surgeries make further strips impossible.

Exclusion criteria

  • • Inadequate donor area.

    • Signs of active disease or infection.
    • Patient who is not willing for long sessions for several hours or multiple sessions as needed due to the slowness of the process
    • Contraindications for surgical procedure as bleeding tendency.
    • Contraindications for PRP as (cardiovascular, autoimmune disorders, hematological disorders and neoplasms).

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

Single Blind

20 participants in 2 patient groups

follicular unit extraction
Experimental group
Description:
extraction of hair follicle unit from donar area and tranplant it into recepient bald area
Treatment:
Procedure: follicular unit extarcation and platelet rich plasma
foolicular unit extraction and platelet rich plasma
Experimental group
Description:
the same procedure mentioned above coupled with session of platelet rich plasma before and after transplantation
Treatment:
Procedure: follicular unit extarcation and platelet rich plasma

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems